These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6790170)

  • 1. Serum hormones and lipoproteins in benign breast disease.
    Sundaram GS; London R; Margolis S; Wenk R; Lustgarten J; Nair PP; Goldstein P
    Cancer Res; 1981 Sep; 41(9 Pt 2):3814-6. PubMed ID: 6790170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Tocopherol and serum lipoproteins.
    Sundaram GS; London R; Manimekalai S; Nair PP; Goldstein P
    Lipids; 1981 Apr; 16(4):223-7. PubMed ID: 7242274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
    Golinger RC; Krebs J; Fisher ER; Danowski TS
    Surgery; 1978 Aug; 84(2):212-5. PubMed ID: 684613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4655-9. PubMed ID: 922746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine parameters and alpha-tocopherol therapy of patients with mammary dysplasia.
    London RS; Sundaram GS; Schultz M; Nair PP; Goldstein PJ
    Cancer Res; 1981 Sep; 41(9 Pt 2):3811-3. PubMed ID: 7020937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sex hormones in premenopausal women with coronary heart disease.
    Mohamad MJ; Karayyem M; Mohammad MA; Al-Alami J; Al-Hader A
    Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease.
    He H; Yang F; Liu X; Zeng X; Hu Q; Zhu Q; Tu B
    Menopause; 2007; 14(3 Pt 1):385-90. PubMed ID: 17108845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of serum cholesterol, high-density lipoprotein and serum lipoprotein electrophoretogram in senior patients with cerebral infarction].
    Yin J; Wang XY; Zhang M
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):844-6. PubMed ID: 12919915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between sex hormones and lipid profile in men with coronary artery disease.
    Wranicz JK; Cygankiewicz I; Rosiak M; Kula P; Kula K; Zareba W
    Int J Cardiol; 2005 May; 101(1):105-10. PubMed ID: 15860391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
    Somogyi A; Herold M; Kocsis I; Nagy G; Somfai G; Studinger P
    Orv Hetil; 2005 Aug; 146(35):1813-8. PubMed ID: 16187540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome].
    Hu WH; Qiao J; Li R; Wang LN
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3186-9. PubMed ID: 17313783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.